Centre for Clinical Microbiology Meeting

Slides:



Advertisements
Similar presentations
Setting up a Molecular Lab in a Developing Country
Advertisements

Global Consultation on the Implementation of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB M. Akhalaia, MD, Microbiologist, Reference.
TanZamBo CAPACITY BUILDING FOR HIV PREVENTION RESEARCH NETWORK Dr Rosemary Musonda TanZamBo PI Lab Director/Research Associate.
Improving diagnosis TB laboratory strengthening.
Improving and Harmonizing Operational Research in Tuberculosis Anthony D Harries The Union, Paris, France.
Implementation of Diagnostics in Resource-Limited Settings Amy Piatek Global Health Bureau, Office of Health, Infectious Diseases & Nutrition U.S. Agency.
High Rates of Tuberculosis in Patients Accessing HAART in Rural South Africa – Implications for HIV and TB Treatment Programs Kogieleum Naidoo on behalf.
Administrative Data Research Centre for England 1.
0 African Network for Drugs & Diagnostics Innovation Dr. Alexander Ochem.
Department of Public Health and Social Services Guam Public Health Laboratory (GPHL) March 11, 2014.
1 Institute of Epidemiology and Infectious Diseases Research Activities The L.V. Gromashevsky Institute of Epidemiology and Infectious Diseases Svetlana.
TUBERCOLOSIS Agis Terzidis, Paediatrician Spyridon Gialamas, Medical Doctor SEMINAR ON TROPICAL AND TRAVEL MEDICINE AT TTCIH IFAKARA 25 JUNE 2009.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Revised National Tuberculosis Control Programme (RNTCP)
 HIV & AIDS are a very serious threat in Zambia, a poor-resource developing country of 13.5 million inhabitants in sub-Saharan Africa and presents significant.
Professor Tumani Corrah CBE, PhD, FRCP, PWACP. Director, Africa Research Development, Medical Research Council UK & Emeritus Director, MRC Unit, The Gambia.
National TB/ Leprosy Programme Manager
The Global Plan to Stop TB, (1)
EQUI - TB Knowledge Programme Quality Assured TB Care for Poor People in Resource Constrained settings 2001 – 2006 Purpose: To promote implementation of.
CITAM+ Engaging HIV Civil Society in TB ACSM Meeting, Cancun 30 Nov 2009 Carol Nawina Nyirenda National Coordinator Community Initiative for TB, HIV/AIDS.
22 March 2012 Europe and ACP together against tuberculosis European Parliament, Rue Wiertz 60 BRUSSELS Charles S Mgone EDCTP Executive Director.
The South African Malaria Initiative A Case Study E Jane Morris Bridging the Gap in Global Health Innovation - from Needs to.
Molecular methods for TB drug resistance testing: what is needed? Experience from Khayelitsha, Cape Town, South Africa Helen Cox, PhD, Burnet Institute.
Africa Herbal Antimalaria Meeting Nairobi, March 2006 Research on Traditional Medicines used for the Treatment of Malaria in WHO African Region Traditional.
Characteristics and Outcomes of a Population of Tuberculosis Inpatients in Lilongwe, Malawi Mina Hosseinipour, MD, MPH Clinical Director UNC Project Lilongwe,
MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.
PUTTING AN END TO TB WHERE ARE THE OPPORTUNITIES AND WHAT ARE THE CHALLENGES? STRATEGY MEETING ON RESOURCE MOBILIZATION FOR THE GLOBAL FUND TO FIGHT AIDS,
HIV Therapy for the Developing World: A Global Health Challenge Harold W. Jaffe, MD Department of Public Health University of Oxford Oxford, UK.
The Chief Scientist Office. Developments/Restructuring Of Research Funding In Scotland Overview of NHS Infrastructure funding ( ) What we have.
Operational Research in the 21 st Century. International Union Against Tuberculosis and Lung Disease (The Union) World’s oldest humanitarian organization.
DR CHIDI V NWENEKA EXECUTIVE DIRECTOR AFRICAN AIDS VACCINE PARTNERSHIP AAVP and the Promotion of HIV Vaccines in Africa: Supporting Career Development.
British Society for Microbial Technology The laboratory diagnosis of tuberculosis 25 years of progress D A Mitchison St George’s, University of London.
The Research and Development Goals of the Global Plan to Stop TB Marcos Espinal Executive Secretary.
IRSS – Centre Muraz : A collaborative research initiative for the promotion of Health in Africa Maxime Koiné DRABO MD, MPH, PhD.
European HIV/AIDS programmes: EDCTP as a model of Europe-Africa partnership 19 July 2011 IAS 2011 Rome, Italy Charles S Mgone EDCTP Executive Director.
Revision of new diagnostics for TB
The School’s Research Environment Anne Mills Deputy Director and Provost Improving health worldwide
What is Operations Research (OR) and Implementation Research (IR)? What isn't? George Schmid World Health Organization/Centers for Disease Control and.
PERSPECTIVES FROM THE FIELD DR LYDIA MUNGHERERA TASO (The Aids Support Organisation) UGANDA REVERSING THE TIDE OF TB.
ZAMSTAR  24 communities in 2 countries  > 1million people  Embedded in the health systems of the 2 countries  Study end point will be prevalence surveys.
Methodological quality of malaria RCTs conducted in Africa Vittoria Lutje*^, Annette Gerritsen**, Nandi Siegfried***. *Cochrane Infectious Diseases Group.
Dr Justin O’Grady. Zambia is a high burden TB and high HIV setting 44,154 TB cases notified in 2010 – incidence of 462/100,000 pop Approx 48% of pulmonary.
Early DETECTion and integrated management of TuBerculosis in europe: E-DETECT TB Professor Ibrahim Abubakar Director, Institute for Global Health University.
REMoxTB – a microbiological challenge Dr Anna Bateson Dr. Tim McHugh, Robert Hunt, Emma Cunningham (Emily Bongard, Holly Ciesielczuk)
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS Identification of Mycobacterium tuberculosis complex in clinical specimens of HIV-infected patients at Instituto.
New technology for an old disease
Emergence of Clinically Relevant
Community Participation in Research
Dr Ousmane Sarr WANETAM
Positive signals of MGIT cultures in the BACTEC 960 system
Prisons and TB in Europe
CAPRISA Advanced Clinical Care Presented by: Nesri Padayatchi
Laboratory diagnosis and biosafety issues of biological warfare agents
Kubelekela antomwe: Ag obair le chéile Working together
Progress in Implementing collaborative TB/HIV activities
Dr Lars Moller, PhD Project Manager Health in Prisons Project
William Burman Denver Public Health Tuberculosis Trials Consortium
Global funding trends for malaria research in sub-Saharan Africa: a systematic analysis  Dr Michael G Head, PhD, Sian Goss, MSc, Yann Gelister, MSc, Victor.
8-9 August 2009, Bali, Indonesia
INTEGRATE satellite symposium AIDS 2018, Amsterdam, the Netherlands
Key issues in DOTS implementation
World Tuberculosis Day 2016
Global funding trends for malaria research in sub-Saharan Africa: a systematic analysis  Dr Michael G Head, PhD, Sian Goss, MSc, Yann Gelister, MSc, Victor.
The Role of NICs in Influenza Surveillance
Vietnam Investment and Finance for TB
Laboratory diagnosis and biosafety issues of biological warfare agents
Work Package 7 Sarah Edwards – Professor of Bioethics, UCL
Abstracts Clinical Microbiology and Infection
The rapid molecular test Xpert MTB/RIF ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection  O. Opota, J. Mazza-Stalder,
Presentation transcript:

Centre for Clinical Microbiology Meeting Capacity Development for TB-NEAT Samana Schwank, PhD Centre for Clinical Microbiology Meeting 11th of January 2012

OVERVIEW What is TB-NEAT? What is the UNZA/UCLMS partnership? What are the outputs of this partnership? Capacity Development for TB-NEAT Future Directions of TB-NEAT

TB-NEAT Novel and emerging technologies for TB diagnosis, in smear- negative and HIV-infected persons, in high burden countries. Funded by the European and Developing Countries Clinical Trials Partnership and the MRC Eg. Evaluation of GeneXpert, LAM, LAMP, Hain etc

UNZA/UCLMS UNZA/ UCLMS The University of Zambia - University College London Medical School (UNZA-UCLMS) Research and Training Project  African scientist-led, south-north partnership Existing for 17 years Over 20 million Euros obtained for research grant funding At least 132 publications have resulted from this collaboration 72 of the publications are led by Zambian authors (16 Lancet papers) Training of staff from the University of Zambia Development of national and international networks Clinical trials expertise This partnership has resulted in several international prizes being awarded

Current International R&D Network UNZA/UCLMS Current International R&D Network

UNZA-UCLMS Paediatric TB Publications

Publishing in collaboration with Zambian scientists CAPACITY DEVELOPMENT Capacity Development Planning and providing courses for African scientists involved in TB-NEAT research Publishing in collaboration with Zambian scientists Collaborate on evaluating TB diagnostics methods together with scientists in Zambia

CAPACITY DEVELOPMENT Providing and arranging courses for scientists involved in TB-NEAT research A course entitled ‘From DNA to Molecular Diagnostics’ was given in August 2011 at UNZA A course is planned in 2012 at UNZA for all TB-NEAT researchers, covering: -Economics of diagnostics -Drug resistance -Overview of current TB diagnostic methods -Bioethics course -Lab practical  

CAPACITY DEVELOPMENT 2. Publishing in collaboration with Zambian scientists Trends of Zambia's tuberculosis burden over the past two decades. 2011. Kapata N, Chanda-Kapata P, O'Grady J, Schwank S, Bates M, Mukonka V, Zumla A, Mwaba P. Trop Med Int Health. 2011 Jul 29. doi: 10.1111/j.1365-3156.2011.02849  

CAPACITY DEVELOPMENT 3. Collaborate to evaluating TB diagnostics methods with scientists from UNZA Evaluation of NTMs in Zambia Objective: Learn about NTM prevalence in Zambia and evaluate NTM diagnostic tests currently used, such as the HAIN CM and AS kit.  Methods: Positive BACTEC MGIT 960 cultures DNA will be extracted Real-time PCR will be run on all positive samples Samples that are not within the MTC, will be identified with the speciation Hain kit Samples where the Hain kit was used will be sequenced All species will be identified by blasting the sequence Goal: -Accuarcy of Hain kit? -Species found? -HIV and NTMs?

FUTURE DIRECTIONS Providing further support to Zambian scientists in the laboratory and providing support for publishing research Aid Zambian scientists to enrol in PhD programmes Hold the international capacity development course on TB diagnostics in Lusaka in 2012 Publish the NTM study

Collaborators: UCL-UNZA-LMU Acknowledgements Collaborators: UCL-UNZA-LMU